Evidence map›Paper›PMID 30333309›Full record

ArticleJCI insight2018

Histone H2A monoubiquitylation and p38-MAPKs regulate immediate-early gene-like reactivation of latent retrovirus HTLV-1.

Anurag Kulkarni, Graham P Taylor, Robert J Klose, Christopher J Schofield, Charles Rm Bangham

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anurag KulkarniDivision of Infectious Diseases, Department of Medicine, Imperial College, London, United Kingdom.
Graham P TaylorDivision of Infectious Diseases, Department of Medicine, Imperial College, London, United Kingdom.
Robert J KloseLaboratory of Chromatin Biology and Transcription, Department of Biochemistry, and.
Christopher J SchofieldChemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, United Kingdom.
Charles Rm BanghamDivision of Infectious Diseases, Department of Medicine, Imperial College, London, United Kingdom.
Imperial College London · GBUniversity of Oxford · GB

Funding

Department of HealthMedical Research Council MR/K019090/1Wellcome Trust 207477/Z/17/ZWellcome Trust 209400/Z/17/ZWellcome Trust WT100291MA
6 · The paper itself

Abstract

It is not understood how the human T cell leukemia virus human T-lymphotropic virus-1 (HTLV-1), a retrovirus, regulates the in vivo balance between transcriptional latency and reactivation. The HTLV-1 proviral plus-strand is typically transcriptionally silent in freshly isolated peripheral blood mononuclear cells from infected individuals, but after short-term ex vivo culture, there is a strong, spontaneous burst of proviral plus-strand transcription. Here, we demonstrate that proviral reactivation in freshly isolated, naturally infected primary CD4+ T cells has 3 key attributes characteristic of an immediate-early gene. Plus-strand transcription is p38-MAPK dependent and is not inhibited by protein synthesis inhibitors. Ubiquitylation of histone H2A (H2AK119ub1), a signature of polycomb repressive complex-1 (PRC1), is enriched at the latent HTLV-1 provirus, and immediate-early proviral reactivation is associated with rapid deubiquitylation of H2A at the provirus. Inhibition of deubiquitylation by the deubiquitinase (DUB) inhibitor PR619 reverses H2AK119ub1 depletion and strongly inhibits plus-strand transcription. We conclude that the HTLV-1 proviral plus-strand is regulated with characteristics of a cellular immediate-early gene, with a PRC1-dependent bivalent promoter sensitive to p38-MAPK signaling. Finally, we compare the epigenetic signatures of p38-MAPK inhibition, DUB inhibition, and glucose deprivation at the HTLV-1 provirus, and we show that these pathways act as independent checkpoints regulating proviral reactivation from latency.

Indexed as

AdultAgedAminopyridinesCD4-Positive T-LymphocytesCell Cycle ProteinsDeubiquitinating EnzymesEpigenesis, GeneticFemaleGene Expression Regulation, ViralGenes, Immediate-EarlyHistonesHTLV-I InfectionsHumansHuman T-lymphotropic virus 1MaleMAP Kinase Signaling System2,6-diaminopyridine-3,5-bis(thiocyanate)AminopyridinesCell Cycle ProteinsDeubiquitinating EnzymesHistonesPRC1 protein, humanThiocyanatesCell stressEpigeneticsTranscriptionVirology

Identifiers

PMID30333309
PMCPMC6237452
OpenAlexW2897534832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.